Edition:
United States

Evofem Biosciences Inc (EVFM.OQ)

EVFM.OQ on NASDAQ Stock Exchange Capital Market

7.45USD
10:25am EST
Change (% chg)

$0.04 (+0.54%)
Prev Close
$7.41
Open
$7.30
Day's High
$7.45
Day's Low
$7.30
Volume
3,312
Avg. Vol
38,899
52-wk High
$15.60
52-wk Low
$1.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.784
Jun '17 0.00 -1.221
Mar '17 0.00 -1.310
FY 2016 Dec '16 0.00 -0.855
Sep '16 0.00 -1.026
Jun '16 0.00 -1.155
Mar '16 0.00 -2.628
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.98 34.59
P/E High - Last 5 Yrs. -- 40.44 45.93
P/E Low - Last 5 Yrs. -- 23.35 24.19
Beta -- 0.82 0.81
Price to Sales (TTM) -- 5.68 8.08
Price to Book (MRQ) 3.52 4.36 5.24
Price to Tangible Book (MRQ) 3.53 4.90 6.43
Price to Cash Flow (TTM) -- 22.95 25.98
% Owned Institutions 26.42 1.24 2.27

Dividends

  Company industry sector
Dividend Yield -- 1.60 1.52
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.22 5.21
Payout Ratio(TTM) -- 43.76 43.34

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.49 9.76
Sales (TTM) vs TTM 1 Yr. Ago -- 6.41 7.61
Sales - 5 Yr. Growth Rate -- 9.87 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 23.63 16.81 18.78
EPS (TTM) vs TTM 1 Yr. Ago 53.47 -- --
EPS - 5 Yr. Growth Rate -- 10.44 11.55
Capital Spending - 5 Yr. Growth Rate -- 14.57 14.73

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.40 2.42
Current Ratio (MRQ) 4.39 3.34 3.39
LT Debt to Equity (MRQ) 0.00 9.39 12.18
Total Debt to Equity (MRQ) 0.00 12.62 15.60
Interest Coverage (TTM) -15.20 44.43 38.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.20 54.74
Gross Margin - 5 Yr. Avg. -- 52.46 52.50
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.43 14.67
Operating Margin (TTM) -- 11.85 4.40
Operating Margin - 5 Yr. Avg. -- 14.25 9.99
Pre-Tax Margin (TTM) -- 12.22 5.14
Pre-Tax Margin - 5 Yr. Avg. -- 14.51 10.24
Net Profit Margin (TTM) -- 8.65 1.86
Net Profit Margin - 5 Yr. Avg. -- 10.86 6.55
Effective Tax Rate (TTM) -- 22.18 21.87
Effective Tax Rate - 5 Yr. Avg. -- 23.50 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 924,143,029 823,803,020
Net Income/Employee (TTM) -- 108,124,219 96,327,335
Receivable Turnover (TTM) -- 5.35 5.44
Inventory Turnover (TTM) -- 2.62 3.52
Asset Turnover (TTM) 0.00 0.93 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -89.56 11.21 10.76
Return on Assets - 5 Yr. Avg. -- 12.69 12.05
Return on Investment (TTM) -103.16 14.12 13.67
Return on Investment - 5 Yr. Avg. -- 16.62 15.78
Return on Equity (TTM) -103.16 15.72 15.40
Return on Equity - 5 Yr. Avg. -- 17.74 17.04
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 70.06 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Evofem Biosciences Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 77.23%
# of Holders: 14
Total Shares Held: 1,782,721
3 Mo. Net Change: 970,602
# New Positions: 3
# Closed Positions: 6
# Increased Positions: 5
# Reduced Positions: 8
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.